| HOME >> BIOLOGY >> TECHNOLOGY |
Agencourt Bioscience Corporation, a wholly owned subsidiary of Beckman Coulter, is a leading provider of nucleic acid purification products and genomic services for life science research. The company's products and services are based on the patented Agencourt SPRI(R) (Solid Phase Reversible Immobilization) paramagnetic bead-based technology.
Beckman Coulter, Inc., based in Fullerton, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represents more than 75 percent of the company's 2006 annual revenue of $2.53 billion. For more information, visit http://www.beckmancoulter.com.
To view the Johns Hopkins Kimmel Cancer Center news release please copy and paste the following link into your browser: http://www.hopkinskimmelcancercenter.org/news/index.cfm?documentid=931&news typ e=News%20Releases&action=showthisitem
Contacts: Jennifer Dahlgren, Dahlgren Communications
Phone: (530) 265-0538
E-mail: jdahlgren@gv.net
Lynn Doucette-Stamm, Ph.D. Agencourt Bioscience Corporation
'/>"/>
| SOURCE Agencourt Bioscience Corporation Copyright©2007 PR Newswire. All rights reserved |